Patrick Frost, PhD

Patrick Frost, PhD

May 05, 2016

Group 6 Copy 32
1
Please wait...

About This Project

BBRI and Los Angeles VA Medical Center

Multiple myeloma (MM) is a cancer of the bone marrow made up of plasma cells (a type of antibody-producing white blood cells). Low oxygen levels (called hypoxia) in the bone marrow increases gene expression in MM tumor cells as part of an adaptive survival response. We are targeting this hypoxic response with an experimental drug that blocks expression of these genes to ask if this molecule kills MM in the bone marrow. This is a novel approach to treat MM, an incurable disease.

Blast off!

Browse Other Projects on Experiment

Related Projects

Why be social? The costs and benefits of sociality in spiders

Sociality in spiders is extremely rare, but it has evolved several times. This begs the question: why be social...

Go West, young man: in search of the A00 haplogroup among peoples of Western Cameroon

Welcome to our citizen-science research project on haplogroup A00 in Cameroon! Having successfully sampled the...

Sending the Garden of ETON to Space

In order for longterm space missions to be successful, a renewable food source is needed. We've developed a...

Backer Badge Funded